Gene expression profiling in Alzheimer's disease brain microvessels

Area of Science:

• Neuroscience
• Genomics
• Pathology

Background:

• Alzheimer's disease (AD) lacks effective disease-modifying therapies, potentially due to a narrow research focus on amyloid-β and tau.
• Complex AD pathogenesis may require broader investigations beyond single-target approaches.
• Emerging evidence suggests cerebrovascular factors contribute significantly to AD development.

Purpose of the Study:

• To investigate molecular alterations in human brain microvessels from Alzheimer's disease (AD) patients compared to controls.
• To identify differentially expressed genes and associated pathways in the AD cerebromicrovasculature using microarray analysis.

Main Methods:

• Microarray analysis of 12 matched pairs of AD and control human brain microvessel samples.
• Identification of genes with >2-fold change in expression.
• Gene ontology and pathway analysis using GeneSpringGX software.

Main Results:

• Over 2,000 genes were found to be differentially expressed in AD microvessels.
• Significant alterations were observed in pathways related to immune and inflammatory responses.
• Changes were also noted in signal transduction and nervous system development and function pathways.

Conclusions:

• The study reveals substantial molecular changes in the cerebromicrovasculature of Alzheimer's disease patients.
• These findings implicate immune, inflammatory, and neurodevelopmental pathways in AD pathogenesis.
• The results provide new insights into the role of microvessels in Alzheimer's disease, potentially opening avenues for novel therapeutic strategies.